Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
Seagen Inc.
Rigshospitalet, Denmark
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Seagen Inc.
Shanghai Jiao Tong University School of Medicine
Sunnybrook Health Sciences Centre
University of Colorado, Denver
Memorial Sloan Kettering Cancer Center
University of Wisconsin, Madison
Gruppo Oncologico del Nord-Ovest
Northwestern University
University of Oklahoma
Memorial Sloan Kettering Cancer Center
ImmunityBio, Inc.
M.D. Anderson Cancer Center
Cardiff Oncology
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Emory University
Gruppo Oncologico del Nord-Ovest
M.D. Anderson Cancer Center
The Netherlands Cancer Institute
Thomas Jefferson University
Akeso
University of Colorado, Denver
Pfizer
Grupo Espanol Multidisciplinario del Cancer Digestivo
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Sun Yat-sen University
West China Hospital
AIO-Studien-gGmbH
University of Wisconsin, Madison
University of Texas Southwestern Medical Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Vejle Hospital
National Institutes of Health Clinical Center (CC)
University of Colorado, Denver
Helsinki University Central Hospital
Rutgers, The State University of New Jersey
Actuate Therapeutics Inc.
Oslo University Hospital